PharmaVault
گنجینه اطلاعات داروسازی
The Pharmaceutical Information Vault
Excipient monograph · مونوگراف ماده جانبی
pharmavault.ir
Chlorocresol
کلروکرزول
1Nonproprietary names
- BPChlorocresol
- Ph. Eur.Chlorocresol
- USP–NFChlorocresol
2Synonyms and trade names
4-chloro-m-cresol; p-chloro-m-cresol; chlorocresolum; 2-chloro-5-hydroxytoluene; PCMC; Preventol CMK
3Chemical name and CAS Registry Number
4-Chloro-3-methylphenol · [59-50-7]
UNII 36W53O7109 · PubChem CID 1732
4Empirical formula and molecular weight
C7H7ClO · 142.58
5Functional category
Antimicrobial preservative
Typical concentrations: 0.1–0.2% · Dosage forms: Semi-solid, Sterile (parenteral/ophthalmic)
6Applications in pharmaceutical formulation
A phenolic antimicrobial preservative used mainly in topical creams and emulsions, typically at about 0.1% w/v (up to about 0.2%), and at about 0.1% in some multidose injections. It is not suitable for eye drops because it irritates the eye. At higher concentrations it is used as a disinfectant.
7Description
Colourless or almost white crystals or crystalline powder with a characteristic phenolic odour.
8Typical properties
- Melting point
- about 64–67 °C
- Boiling point
- about 235 °C
- pKa
- about 9.6
- Solubility
- slightly soluble in water (about 1 in 260 at 20 °C, more soluble in hot water); very soluble in ethanol; freely soluble in fixed oils; dissolves in alkali hydroxide solutions
- Antimicrobial spectrum
- bacteria (Gram-positive and Gram-negative) and fungi; more active in acidic than in alkaline solution
9Stability and storage conditions
Stable at room temperature. Aqueous solutions may be sterilised by autoclaving but slowly become yellow on exposure to light and air. Store in a well-closed container, protected from light, in a cool, dry place.
10Incompatibilities
Its activity is reduced by non-ionic surfactants such as polysorbate 80 and by methylcellulose, through micellar solubilisation and binding, and by partitioning into the oil phase of emulsions. It is sorbed by rubber closures and some plastics. It is also reported to be incompatible with calcium chloride, codeine phosphate, diamorphine hydrochloride, papaverine hydrochloride and quinine hydrochloride, and it discolours with iron salts.
11Method of manufacture
Prepared by chlorination of m-cresol, followed by purification.
12Safety
Used mainly in topical preparations, where it is generally well tolerated at preservative levels, although it can irritate the skin and has caused allergic contact dermatitis, with cross-sensitivity to related phenols. It must not be used in products for intrathecal, intracisternal or epidural injection.
13Handling precautions
Observe normal precautions for the quantity handled. Chlorocresol is irritant and corrosive to the skin and eyes in concentrated form; wear eye protection and gloves and avoid inhaling the dust or vapour.
14Regulatory status
Included in non-parenteral medicines and some parenteral medicines licensed in the UK and Europe, and permitted as a preservative in cosmetics in the EU within set limits.
15Related substances
Cresol; metacresol; chloroxylenol; phenol.
16Comments
Because chlorocresol is lipophilic, much of it partitions into the oil phase of creams and into surfactant micelles, so the free aqueous concentration may be well below the nominal amount; confirm efficacy with a preservative effectiveness test. It dissolves faster in warm water.